Abstract
The pharmaceutical industry is definitely a high-tech industry, for its role in discovery of new medicines for the treatment of unmet medical needs. Pharmaceutical manufacturing is complex and sophisticated due to various reasons, but in its current state probably cannot be categorized as really high-tech, too. In fact, pharmaceutical manufacturing was considered as relatively low-tech even by the pharmaceutical companies themselves as recently as in 2002. When ex-FDA commissioner Mark McClellan sought a benchmark for future pharmaceutical manufacturing performance, he looked outside the industry, and challenged Pharma, “You need to improve…Other high-tech industries have achieved enormous productivity gains in manufacturing in the last 25 years. We should expect nothing less from the Pharmaceutical industry.”
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
CAMP Member Companies (2002) Quality by design: a challenge to the pharma industry, March.
- 2.
Abboud L, Hensley S (2003) New prescription for drug makers: update the plants. Wall Street J, 3 Sept 2003.
- 3.
FDA white paper on critical path, Mar 2004.
- 4.
Simon HA (1962) The architecture of complexity. Proc Am Philos Soc 106(6):467–482
- 5.
Basu PK (1998) Pharmaceutical process development is different. Chem Eng Prog 94:75–82
- 6.
Basu PK, Mack RA, Vinson JM (1995) Consider a different approach to pharmaceutical process development. Chem Eng Prog 95:82–90
- 7.
Chatterjee S (2011) Role of models in the Quality by Design (QbD) paradigm: a regulatory perspective. AAPS annual meeting, Aug 2011
- 8.
FDA (2004) Guidance for industry PAT – a framework for innovative pharmaceutical development, manufacturing, and quality assurance
- 9.
Ali Afnan (2011) Real-time release: it’s time for action and not debate. PharmaQbD, 22 Feb 2011
- 10.
FDA (2004) Challenges and opportunity on the critical path to new medical products, Mar 2004
- 11.
Pagnamenta R (2007) AstraZeneca to outsource manufacturing. Times Online. 17 Sept 2007
- 12.
Hensley S (2008) Roche CEO warns big pharma and biotech face rough waters. Health Blog, Wall St J
- 13.
Gasty T The difference between innovation and invention. http://www.pbs.org/idealab/2012/03/the-difference-between-invention-and-innovation086.html
- 14.
Longman R (2008) Arguing by analogy: what pharma can learn from the car business. The RPM report, 20 Nov 2008
- 15.
- 16.
Juran JM (1993) Made in U.S.A.: a renaissance in quality. Har Bus Rev, Jul–Aug
- 17.
Pisano G, Shih WC (2009) Restoring American competitiveness. Har Bus Rev, July–Aug
- 18.
Wise E (2008) USA Today, 19 Mar 2008
- 19.
Woodcock J, Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther 93(2)
- 20.
Moad J (2013) www.manufacturing-executive.com. 6 Feb 2013
- 21.
Browning LD, Shelter JC (2000) Sematech: saving the US semiconductor industry. Texas A&M University Press, College Station.
- 22.
Pittaway L et al (2004) Networking and innovation: a systematic review of the evidence. Int J Manag Rev 5(3–4):137–168
- 23.
Pennings JM, Harianto F (2013) Technological networking and innovation implementation. Organ Sci 24:1, Jan–Feb
- 24.
Olsen JT (1985) The state of quality in the U.S. Today. Qual Prog 33
- 25.
Hayes RH, Wheelwright SC (1984) Restoring our competitive edge. Wiley
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Basu, P., Friedli, T., Bellm, D. (2013). The Future of Pharmaceutical Manufacturing. In: Friedli, T., Basu, P., Bellm, D., Werani, J. (eds) Leading Pharmaceutical Operational Excellence. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35161-7_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-35161-7_29
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35160-0
Online ISBN: 978-3-642-35161-7
eBook Packages: Business and EconomicsBusiness and Management (R0)